Recreational cannabis may not pair well with diabetes, according to a review of recent studies that examined the effects of the drug on people living with type 1 or type 2 versions of the disease.
The review, which was commissioned by Diabetes Canada, narrowed its focus to six observational studies in an attempt to better understand the interaction between cannabis and the disease that prevents people from producing insulin or properly using the insulin it produces. The results were not encouraging.
“Recreational cannabis use may negatively impact diabetes metabolic factors and self-management behaviours in people with T1D,” the researchers noted. “In people with T2D, recreational cannabis may increase risks for peripheral arterial occlusion, myocardial infarction and renal disease,” they added.